QIAGEN Shares Outstanding 2006-2018 | QGEN

QIAGEN shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

QIAGEN shares outstanding for the quarter ending September 30, 2018 were 0.235B, a 1.04% increase year-over-year.
QIAGEN 2017 shares outstanding were 0.233B, a 2.5% decline from 2016.
QIAGEN 2016 shares outstanding were 0.239B, a 0.14% increase from 2015.
QIAGEN 2015 shares outstanding were 0.239B, a 1.71% decline from 2014.

QIAGEN Annual Shares Outstanding (Millions of Shares)
2017	233
2016	239
2015	239
2014	243
2013	233
2012	232
2011	230
2010	232
2009	206
2008	197
2007	169
2006	148
2005	145

QIAGEN Quarterly Shares Outstanding (Millions of Shares)
Q3 2018	235
Q2 2018	234
Q1 2018	233
Q4 2017	233
Q3 2017	233
Q2 2017	233
Q1 2017	235
Q4 2016	239
Q3 2016	239
Q2 2016	239
Q1 2016	238
Q4 2015	239
Q3 2015	228
Q2 2015	228
Q1 2015	229
Q4 2014	243
Q3 2014	232
Q2 2014	232
Q1 2014	234
Q4 2013	233
Q3 2013	233
Q2 2013	225
Q1 2013	233
Q4 2012	232
Q3 2012	233
Q2 2012	231
Q1 2012	230
Q4 2011	230
Q3 2011	229
Q2 2011	232
Q1 2011	231
Q4 2010	231
Q3 2010	230
Q2 2010	233
Q1 2010	227
Q4 2009	232
Q3 2009	201
Q2 2009	196
Q1 2009	196
Q4 2008	195
Q3 2008	197
Q2 2008	198
Q1 2008	198
Q4 2007	206
Q3 2007	179
Q2 2007	151
Q1 2007	147
Q4 2006	149
Q3 2006	148
Q2 2006	148
Q1 2006	147
Q4 2005	144
Q3 2005	145
Q2 2005	144
Q1 2005	144

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$7.997B	$1.418B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$125.010B	14.13
Gilead Sciences (GILD)	United States	$87.604B	10.55
Biogen (BIIB)	United States	$64.432B	13.05
Celgene (CELG)	United States	$48.591B	9.43
Illumina (ILMN)	United States	$48.348B	56.32
Vertex Pharmaceuticals (VRTX)	United States	$44.270B	77.33
Regeneron Pharmaceuticals (REGN)	United States	$40.656B	20.60
Alexion Pharmaceuticals (ALXN)	United States	$25.618B	17.53
BioMarin Pharmaceutical (BMRN)	United States	$16.442B	0.00
Incyte (INCY)	United States	$13.960B	385.88
Seattle Genetics (SGEN)	United States	$9.759B	0.00
Exact Sciences (EXAS)	United States	$8.544B	0.00
Sarepta Therapeutics (SRPT)	United States	$8.353B	0.00
BeiGene (BGNE)	Cayman Islands	$8.129B	0.00
Alnylam Pharmaceuticals (ALNY)	United States	$7.758B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$7.571B	48.41
Exelixis (EXEL)	United States	$6.273B	17.78
Bio-Techne Corp (TECH)	United States	$5.949B	40.19
Bluebird Bio (BLUE)	United States	$5.733B	0.00
Alkermes (ALKS)	Ireland	$5.356B	3447.00
Amarin (AMRN)	Ireland	$5.351B	0.00
Galapagos (GLPG)	Belgium	$5.260B	0.00
Guardant Health (GH)	United States	$3.751B	0.00
Immunomedics (IMMU)	United States	$3.590B	0.00
MorphoSys AG Unsponsored ADR (MOR)	Germany	$3.546B	0.00
Emergent Biosolutions (EBS)	United States	$3.378B	28.46
Array BioPharma (ARRY)	United States	$3.292B	0.00
Horizon Pharma Public (HZNP)	Ireland	$3.279B	13.49
ARGENX SE-ADR (ARGX)	Netherlands	$3.217B	0.00
Allogene Therapeutics (ALLO)	United States	$3.157B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.115B	23.83
Intercept Pharmaceuticals (ICPT)	United States	$3.102B	0.00
Akcea Therapeutics (AKCA)	United States	$2.861B	0.00
Repligen (RGEN)	United States	$2.713B	84.74
Ascendis Pharma (ASND)	Denmark	$2.613B	0.00
Allakos (ALLK)	United States	$2.590B	0.00
Genomic Health (GHDX)	United States	$2.586B	87.32
Blueprint Medicines (BPMC)	United States	$2.512B	0.00
China Biologic Products (CBPO)	China	$2.474B	17.61
ACADIA Pharmaceuticals (ACAD)	United States	$2.323B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.312B	0.00
Myriad Genetics (MYGN)	United States	$2.302B	22.81
Halozyme Therapeutics (HALO)	United States	$2.235B	49.87
Global Blood Therapeutics (GBT)	United States	$2.234B	0.00
Acceleron Pharma (XLRN)	United States	$2.212B	0.00
MyoKardia (MYOK)	United States	$2.194B	0.00
Arena Pharmaceuticals (ARNA)	United States	$2.024B	0.00
Amicus Therapeutics (FOLD)	United States	$1.999B	0.00
Denali Therapeutics (DNLI)	United States	$1.941B	0.00
Atara Biotherapeutics (ATRA)	United States	$1.934B	0.00
AnaptysBio (ANAB)	United States	$1.918B	0.00
REGENXBIO (RGNX)	United States	$1.915B	25.69
CRISPR Therapeutics AG (CRSP)	Switzerland	$1.853B	0.00
Innoviva (INVA)	United States	$1.766B	9.99
Reata Pharmaceuticals (RETA)	United States	$1.763B	0.00
Spark Therapeutics (ONCE)	United States	$1.540B	0.00
Medicines (MDCO)	United States	$1.529B	0.00
Cambrex (CBM)	United States	$1.484B	11.08
Rubius Therapeutics (RUBY)	United States	$1.483B	0.00
Biohaven Pharmaceutical Holding (BHVN)	United States	$1.476B	0.00
WAVE Life Sciences (WVE)	Singapore	$1.425B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$1.425B	113.17
Editas Medicine (EDIT)	United States	$1.415B	0.00
Nabriva Therapeutics AG (NBRV)	Ireland	$1.380B	0.00
Aimmune Therapeutics (AIMT)	United States	$1.364B	0.00
Autolus Therapeutics Sponsored ADR (AUTL)	United Kingdom	$1.332B	0.00
Mirati Therapeutics (MRTX)	United States	$1.309B	0.00
ORCHARD THERAPT (ORTX)	United Kingdom	$1.308B	0.00
NeoGenomics (NEO)	United States	$1.290B	106.69
Myovant Sciences (MYOV)	United Kingdom	$1.236B	0.00
G1 THERAPEUTICS (GTHX)	United States	$1.233B	0.00
Lion Biotechnologies (IOVA)	United States	$1.222B	0.00
Kiniksa Pharmaceuticals (KNSA)	Bermuda	$1.206B	0.00
Insmed (INSM)	United States	$1.200B	0.00
Sangamo Therapeutics (SGMO)	United States	$1.199B	0.00
Zai Lab Unsponsored ADR (ZLAB)	China	$1.169B	0.00
Clovis Oncology (CLVS)	United States	$1.132B	0.00
UniQure (QURE)	Netherlands	$1.071B	0.00
Fate Therapeutics (FATE)	United States	$1.056B	0.00
Deciphera Pharmaceuticals (DCPH)	United States	$1.022B	0.00
Apellis Pharmaceuticals (APLS)	United States	$1.009B	0.00
Retrophin (RTRX)	United States	$1.003B	0.00
Audentes Therapeutics (BOLD)	United States	$1.002B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$0.932B	0.00
Momenta Pharmaceuticals (MNTA)	United States	$0.909B	0.00
Puma Biotechnology (PBYI)	United States	$0.897B	0.00
Novavax (NVAX)	United States	$0.854B	0.00
Intra-Cellular Therapies (ITCI)	United States	$0.847B	0.00
Solid Biosciences (SLDB)	United States	$0.840B	0.00
Cellectis (CLLS)	France	$0.835B	0.00
DBV Technologies (DBVT)	France	$0.821B	0.00
Athenex (ATNX)	United States	$0.817B	0.00
Dicerna Pharmaceuticals (DRNA)	United States	$0.806B	0.00
Revance Therapeutics (RVNC)	United States	$0.804B	0.00
Alder BioPharmaceuticals (ALDR)	United States	$0.781B	0.00
Acorda Therapeutics (ACOR)	United States	$0.769B	9.73
Vericel (VCEL)	United States	$0.761B	0.00
AC Immune SA (ACIU)	Switzerland	$0.761B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.752B	0.00
Y-mAbs Therapeutics (YMAB)	United States	$0.751B	0.00
Heska (HSKA)	United States	$0.740B	60.60
Aptinyx (APTX)	United States	$0.732B	0.00
Gritstone Oncology (GRTS)	United States	$0.731B	0.00
Intellia Therapeutics (NTLA)	United States	$0.716B	0.00
Principia Biopharma (PRNB)	United States	$0.701B	0.00
InflaRx (IFRX)	Germany	$0.688B	0.00
Dynavax Technologies (DVAX)	United States	$0.678B	0.00
Scholar Rock Holding (SRRK)	United States	$0.678B	0.00
Viking Therapeutics (VKTX)	United States	$0.677B	0.00
Coherus BioSciences (CHRS)	United States	$0.672B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.665B	0.00
CytomX Therapeutics (CTMX)	United States	$0.654B	0.00
Inotek Pharmaceuticals (RCKT)	United States	$0.648B	0.00
ANI Pharmaceuticals (ANIP)	United States	$0.646B	12.36
UROGEN PHARMA (URGN)	Israel	$0.626B	0.00
UNITY Biotechnology (UBX)		$0.621B	0.00
Cara Therapeutics (CARA)	United States	$0.617B	0.00
TWIST BIOSCIENC (TWST)	United States	$0.612B	0.00
AMAG Pharmaceuticals (AMAG)	United States	$0.609B	0.00
AVROBIO (AVRO)	United States	$0.589B	0.00
NuCana Sponsored ADR (NCNA)	United Kingdom	$0.548B	0.00
Arvinas (ARVN)	United States	$0.544B	0.00
Adaptimmune Therapeutics (ADAP)	United Kingdom	$0.543B	0.00
Arcus Biosciences (RCUS)	United States	$0.540B	0.00
ObsEva SA (OBSV)	Switzerland	$0.534B	0.00
Kura Oncology (KURA)	United States	$0.533B	0.00
Eidos Therapeutics (EIDX)	United States	$0.521B	0.00
RA PHARMCTL INC (RARX)	United States	$0.515B	0.00
Kezar Life Sciences (KZR)	United States	$0.513B	0.00
Epizyme (EPZM)	United States	$0.512B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.495B	0.00
Osiris Therapeutics (OSIR)	United States	$0.486B	0.00
BeyondSpring (BYSI)	United States	$0.478B	0.00
Prothena (PRTA)	Ireland	$0.464B	0.00
Zymeworks (ZYME)	Canada	$0.462B	0.00
Senesco Technologies (ELOX)	United States	$0.459B	0.00
ZIOPHARM Oncology Inc (ZIOP)	United States	$0.453B	0.00
Anika Therapeutics (ANIK)	United States	$0.445B	18.42
Replimune (REPL)	United States	$0.440B	0.00
PDL BioPharma (PDLI)	United States	$0.436B	7.12
Cytokineticsorporated (CYTK)	United States	$0.436B	0.00
Five Prime Therapeutics (FPRX)	United States	$0.427B	0.00
Achillion Pharmaceuticals (ACHN)	United States	$0.423B	0.00
Kindred Biosciences (KIN)	United States	$0.420B	0.00
Sinovac Biotech (SVA)	China	$0.405B	0.00
Zealand Pharma (ZEAL)	Denmark	$0.392B	4.32
Mesoblast (MESO)	Australia	$0.388B	0.00
Clementia Pharmaceuticals (CMTA)	Canada	$0.385B	0.00
Abeona Therapeutics (ABEO)	United States	$0.382B	0.00
Cellular Biomedicine (CBMG)	United States	$0.373B	0.00
MediciNova (MNOV)	United States	$0.369B	0.00
ResTORbio (TORC)	United States	$0.354B	0.00
Keryx Biopharmaceuticals (KERX)	United States	$0.351B	0.00
Nightstar Therapeutics Sponsored ADR (NITE)	United States	$0.345B	0.00
Liquidia Technologies (LQDA)	United States	$0.343B	0.00
Stemline Therapeutics (STML)	United States	$0.338B	0.00
Krystal Biotech (KRYS)	United States	$0.336B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.331B	0.00
Sorrento Therapeutics (SRNE)	United States	$0.326B	53.40
Verastem (VSTM)	United States	$0.322B	0.00
Kodiak Sciences (KOD)	United States	$0.319B	0.00
Evelo Biosciences (EVLO)	United States	$0.317B	0.00
Agenus (AGEN)	United States	$0.314B	0.00
LogicBio Therapeutics (LOGC)	United States	$0.310B	0.00
Albireo Pharma (ALBO)	United States	$0.306B	0.00
Athersys (ATHX)	United States	$0.295B	0.00
Peregrine Pharmaceuticals (CDMO)	United States	$0.285B	0.00
Seres Therapeutics (MCRB)	United States	$0.283B	0.00
MannKind (MNKD)	United States	$0.278B	0.00
Syros Pharmaceuticals (SYRS)	United States	$0.277B	0.00
Magenta Therapeutics (MGTA)	United States	$0.276B	0.00
Merus (MRUS)	Netherlands	$0.274B	0.00
Biofrontera AG Sponsored ADR (BFRA)	Germany	$0.271B	0.00
GAMIDA CELL LTD (GMDA)	Israel	$0.264B	0.00
Geron (GERN)	United States	$0.261B	0.00
Kadmon Holdings (KDMN)	United States	$0.257B	0.00
TOCAGEN INC (TOCA)	United States	$0.256B	0.00
AVEO Pharmaceuticals (AVEO)	United States	$0.254B	0.00
BioDelivery Sciences (BDSI)	United States	$0.250B	0.00
Equillium (EQ)	United States	$0.250B	0.00
Arbutus Biopharma (ABUS)	Canada	$0.246B	0.00
Intec Pharma (NTEC)	Israel	$0.246B	0.00
Celcuity (CELC)	United States	$0.234B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.232B	0.00
Sutro Biopharma (STRO)	United States	$0.231B	0.00
Celyad SA (CYAD)	Belgium	$0.227B	0.00
Aduro Biotech (ADRO)	United States	$0.222B	0.00
Paratek Pharmaceuticals (PRTK)	United States	$0.221B	0.00
ADMA Biologics Inc (ADMA)	United States	$0.221B	0.00
Eiger BioPharmaceuticals (EIGR)	United States	$0.214B	0.00
Strongbridge Biopharma (SBBP)	United States	$0.213B	0.00
PSivida (EYPT)	United States	$0.208B	0.00
Urovant Sciences (UROV)	United States	$0.195B	0.00
Kamada (KMDA)	Israel	$0.195B	17.96
Aeglea BioTherapeutics (AGLE)	United States	$0.195B	0.00
Kala Pharmaceuticals (KALA)	United States	$0.193B	0.00
Synlogic (SYBX)	United States	$0.187B	0.00
Idera Pharmaceuticals (IDRA)	United States	$0.184B	0.00
Proteostasis Therapeutics (PTI)	United States	$0.181B	0.00
Allena Pharmaceuticals (ALNA)	United States	$0.180B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$0.178B	0.00
Pieris Pharmaceuticals (PIRS)	United States	$0.177B	0.00
Unum Therapeutics (UMRX)	United States	$0.172B	0.00
CorMedix Inc (CRMD)	United States	$0.169B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.165B	0.00
Spring Bank Pharmaceuticals (SBPH)	United States	$0.165B	0.00
BioTime (BTX)	United States	$0.163B	0.00
Protagonist Therapeutics (PTGX)	United States	$0.162B	0.00
Compugen (CGEN)	Israel	$0.162B	0.00
XBiotech (XBIT)	United States	$0.155B	0.00
Palatin Technologies (PTN)	United States	$0.154B	19.00
ChromaDex (CDXC)	United States	$0.154B	0.00
ASLAN Pharmaceuticals (ASLN)	Singapore	$0.154B	0.00
Axovant Sciences (AXON)	United Kingdom	$0.152B	0.00
Cohbar (CWBR)	United States	$0.151B	0.00
Constellation Pharmaceuticals (CNST)	United States	$0.148B	0.00
Enzo Biochem (ENZ)	United States	$0.139B	0.00
Cerecor (CERC)	United States	$0.137B	0.00
Verona Pharma American Depositary Share (VRNA)	United Kingdom	$0.136B	0.00
Menlo Therapeutics (MNLO)	United States	$0.132B	0.00
Erytech Pharma SA Sponsored ADR (ERYP)	France	$0.126B	0.00
Mersana Therapeutics (MRSN)	United States	$0.124B	0.00
Selecta Biosciences (SELB)	United States	$0.122B	0.00
XOMA (XOMA)	United States	$0.122B	0.00
Catalyst Biosciences (CBIO)	United States	$0.121B	0.00
Pfenex (PFNX)	United States	$0.120B	0.00
Organovo Holdings (ONVO)	United States	$0.119B	0.00
Eleven Biotherapeutics (SESN)	United States	$0.118B	0.00
Spero Therapeutics (SPRO)	United States	$0.118B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$0.117B	0.00
NantKwest (NK)	United States	$0.116B	0.00
Applied Genetic Technologies (AGTC)	United States	$0.111B	0.00
Pluristem Therapeutics (PSTI)	Israel	$0.110B	0.00
Cocrystal Pharma (COCP)	United States	$0.105B	117.33
Sienna Biopharmaceuticals (SNNA)	United States	$0.104B	0.00
ETON PHARMACEUT (ETON)	United States	$0.104B	0.00
Axsome Therapeutics (AXSM)	United States	$0.103B	0.00
TIZIANA LIFE SC (TLSA)	United Kingdom	$0.103B	0.00
VBI Vaccines (VBIV)	United States	$0.100B	0.00
Cue Biopharma (CUE)	United States	$0.097B	0.00
Motif Bio Plc (MTFB)	United States	$0.097B	0.00
Anavex Life Sciences (AVXL)	United States	$0.096B	0.00
Nymox Pharmaceutical (NYMX)	Canada	$0.096B	0.00
Signal Genetics (MGEN)	United States	$0.096B	0.00
PHASEBIO PHARMA (PHAS)	United States	$0.095B	0.00
Neothetics (EVFM)	United States	$0.092B	0.00
Chiasma (CHMA)	United States	$0.091B	0.00
Cel-Sci (CVM)	United States	$0.091B	0.00
ScPharmaceuticals (SCPH)	United States	$0.087B	0.00
Mustang Bio (MBIO)	United States	$0.087B	0.00
Provention Bio (PRVB)	United States	$0.086B	0.00
Cidara Therapeutics (CDTX)	United States	$0.083B	0.00
Aptose Biosciences (APTO)	Canada	$0.083B	0.00
Aerpio Pharmaceuticals (ARPO)	United States	$0.082B	0.00
Orgenesis (ORGS)	United States	$0.080B	0.00
OVID THERAPEUTC (OVID)	United States	$0.079B	0.00
VTv Therapeutics (VTVT)	United States	$0.077B	0.00
Monster Digital (INNT)	United States	$0.075B	0.00
VolitionRX (VNRX)	Singapore	$0.073B	0.00
ITUS (ANIX)	United States	$0.073B	0.00
Checkpoint Therapeutics (CKPT)	United States	$0.073B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.071B	0.00
Alimera Sciences (ALIM)	United States	$0.069B	0.00
Bellerophon Therapeutics (BLPH)	United States	$0.067B	0.00
Bionano Genomics (BNGO)	United States	$0.065B	0.00
NewLink Genetics (NLNK)	United States	$0.064B	0.00
Brainstorm Cell Therapeutics (BCLI)	United States	$0.064B	0.00
Prima BioMed (IMMP)	Australia	$0.064B	0.00
Aridis Pharmaceuticals (ARDS)	United States	$0.063B	0.00
Sophiris Bio (SPHS)	United States	$0.062B	0.00
Ophthotech (OPHT)	United States	$0.061B	0.00
Protalix BioTherapeutics (PLX)	Israel	$0.061B	0.00
Vaccinex (VCNX)	United States	$0.060B	0.00
Evogene (EVGN)	Israel	$0.060B	0.00
Fortress Biotech (FBIO)	United States	$0.060B	0.00
Entera Bio (ENTX)	Israel	$0.056B	0.00
Merrimack Pharmaceuticals (MACK)	United States	$0.055B	0.00
Alcobra (ARCT)	United States	$0.055B	0.00
AEterna Zentaris (AEZS)	United States	$0.054B	10.31
Versartis (ARAV)	United States	$0.054B	4.73
VistaGen Therapeutics (VTGN)	United States	$0.053B	0.00
Trevena (TRVN)	United States	$0.052B	0.00
Arsanis (ASNS)	United States	$0.051B	0.00
Asterias Biotherapeutics (AST)	United States	$0.050B	0.00
OncoSec Medical (ONCS)	United States	$0.049B	0.00
Caladrius Biosciences (CLBS)	United States	$0.047B	0.00
Leap Therapeutics (LPTX)	United States	$0.047B	0.00
Aptevo Therapeutics (APVO)	United States	$0.045B	0.00
Celldex Therapeutics (CLDX)	United States	$0.045B	0.00
Zosano Pharma (ZSAN)	United States	$0.044B	0.00
Clearside Biomedical (CLSD)	United States	$0.044B	0.00
Catabasis Pharmaceuticals (CATB)	United States	$0.044B	0.00
Vascular Biogenics (VBLT)	Israel	$0.042B	0.00
Oncobiologics (OTLK)	United States	$0.042B	0.00
Rexahn Pharmaceuticals (RNN)	United States	$0.040B	0.00
Moleculin Biotech (MBRX)	United States	$0.040B	0.00
Eyenovia (EYEN)	United States	$0.038B	0.00
Galena Biopharma (SLS)	United States	$0.038B	0.00
OncoMed Pharmaceuticals (OMED)	United States	$0.037B	5.94
Celsion (CLSN)	United States	$0.036B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.035B	0.00
BiondVax Pharmaceuticals (BVXV)	Israel	$0.035B	0.00
Proteon Therapeutics (PRTO)	United States	$0.034B	0.00
TRACON Pharmaceuticals (TCON)	United States	$0.034B	0.00
AquaBounty Technologies (AQB)	United States	$0.032B	0.00
Oragenics (OGEN)	United States	$0.031B	0.00
GTx (GTXI)	United States	$0.031B	0.00
VIVUS (VVUS)	United States	$0.030B	0.00
AZURRX BIOPHARM (AZRX)	United States	$0.029B	0.00
Aileron Therapeutics (ALRN)	United States	$0.029B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.028B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.028B	0.00
Histogenics (HSGX)	United States	$0.027B	0.00
Vical (VICL)	United States	$0.027B	0.00
BioPharmX (BPMX)	United States	$0.026B	0.00
IMMURON LTD (IMRN)	Australia	$0.026B	0.00
Titan Pharmaceuticals (TTNP)	United States	$0.021B	0.00
Benitec Biopharma (BNTC)	Australia	$0.021B	0.00
Cleveland BioLabs (CBLI)	United States	$0.021B	0.00
Curis (CRIS)	United States	$0.021B	0.00
Novelion Therapeutics (NVLN)	Canada	$0.020B	0.00
Advaxis (ADXS)	United States	$0.019B	0.00
Fibrocell Science Inc (FCSC)	United States	$0.018B	0.00
GENPREX INC (GNPX)	United States	$0.018B	0.00
CytRx (CYTR)	United States	$0.018B	0.00
Pulmatrix (PULM)	United States	$0.018B	0.00
Cellect Biotechnology (APOP)	Israel	$0.017B	0.00
Therapix Biosciences (TRPX)	Israel	$0.017B	8.70
ATyr Pharma (LIFE)	United States	$0.016B	0.00
Soligenix (SNGX)	United States	$0.016B	0.00
TrovaGene (TROV)	United States	$0.016B	0.00
Genetic Technologies (GENE)	Australia	$0.016B	0.00
Gemphire Therapeutics (GEMP)	United States	$0.015B	0.00
Sunesis Pharmaceuticals (SNSS)	United States	$0.015B	0.00
Edge Therapeutics (EDGE)	United States	$0.014B	0.00
Novogen (KZIA)	Australia	$0.013B	0.00
IBio (IBIO)	United States	$0.013B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.013B	0.00
Prana Biotechnology (PRAN)	Australia	$0.012B	0.00
MYOS RENS Technology (MYOS)	United States	$0.011B	0.00
RestorGenex (DFFN)	United States	$0.011B	0.00
Vital Therapies (VTL)	United States	$0.011B	0.00
Alliqua BioMedical (ALQA)	United States	$0.010B	0.00
Cyclacel Pharmaceuticals (CYCC)	United States	$0.010B	0.00
Synthetic Biologics (SYN)	United States	$0.009B	0.00
Hemispherx BioPharma (HEB)	United States	$0.009B	0.00
Cerulean Pharma (DARE)	United States	$0.009B	0.00
Neuralstem (CUR)	United States	$0.008B	0.00
Aytu Bioscience (AYTU)	United States	$0.008B	0.00
Flex Pharma (FLKS)	United States	$0.007B	0.00
ContraVir Pharmaceuticals Inc (CTRV)	United States	$0.007B	0.00
ARCA Biopharma (ABIO)	United States	$0.007B	0.00
AmpliPhi Biosciences (APHB)	United States	$0.006B	0.00
Stellar Biotechnologies (SBOT)	United States	$0.006B	0.00
Cytori Therapeutics Inc (CYTX)	United States	$0.004B	0.00
Tenax Therapeutics (TENX)	United States	$0.002B	0.00
OSMOTICA PHARM (OSMT)	United States	$0.000B	0.00